Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “C. Diff”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableLooking for participantsNCT07250724
What this trial is testing

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Who this might be right for
Clostridioides Difficile Infection Recurrence
Bactolife A/S 60
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Not applicableStudy completedNCT00304408
What this trial is testing

Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody

Who this might be right for
Clostridium EnterocolitisPseudomembranous ColitisAntibiotic-Associated Colitis
Michael E. DeBakey VA Medical Center 10
Large-scale testing (Phase 3)Ended earlyNCT00177775
What this trial is testing

Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea

Who this might be right for
Positive C-Diff Culture
University of Pittsburgh 60
Not applicableStudy completedNCT03117582
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics

Who this might be right for
Clostridium Difficile
University of North Carolina, Chapel Hill 34
Testing effectiveness (Phase 2)Ended earlyNCT02255305
What this trial is testing

FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI

Who this might be right for
Clostridium Difficile Infection
Endeavor Health 6
Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Early research (Phase 1)Study completedNCT04893239
What this trial is testing

Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies

Who this might be right for
C. Diff. Infections
Lumen Bioscience, Inc. 12
Large-scale testing (Phase 3)Study completedNCT00269399
What this trial is testing

A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Clostridium InfectionsDiarrhea
Bausch Health Americas, Inc. 237
Not applicableEnded earlyNCT02076438
What this trial is testing

Probiotics for Prevention of Antibiotic Associated Diarrhea and Clostridium Difficile Associated Disease

Who this might be right for
Diarrhea
Rutgers, The State University of New Jersey 110
Early research (Phase 1)Study completedNCT01551004
What this trial is testing

Phase I Trial of a Single Dose of CRS3123

Who this might be right for
Clostridium Difficile Colitis
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT00446355
What this trial is testing

Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes

Who this might be right for
Clostridium Infections
University of Pittsburgh 1,000
Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Large-scale testing (Phase 3)Ended earlyNCT04802837
What this trial is testing

Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects

Who this might be right for
Clostridioides Difficile Infection
Summit Therapeutics 2
Large-scale testing (Phase 3)Study completedNCT03595553
What this trial is testing

Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Summit Therapeutics 759
Post-approval studies (Phase 4)Ended earlyNCT00177970
What this trial is testing

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
University of Pittsburgh 14
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Testing effectiveness (Phase 2)Study completedNCT03110133
What this trial is testing

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

Who this might be right for
Clostridium Difficile Infection Recurrence
Finch Research and Development LLC. 206
Testing effectiveness (Phase 2)Study completedNCT03788434
What this trial is testing

Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection RecurrenceClostridium Difficile InfectionClostridium Difficile+4 more
Vedanta Biosciences, Inc. 79
Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Load More Results